Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 148, Issue -, Pages 465-476Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2018.02.050
Keywords
Carbazole carboxamides; ROR gamma t inverse agonists; Th17 cells; Autoimmune diseases; Binding mode
Categories
Funding
- National Science Foundation of China [81573276]
- Shanghai Biopharmaceutical Science and Technology Supporting Plan [15431900300, 17431902100]
Ask authors/readers for more resources
A novel series of carbazole carboxamides was discovered as potent ROR gamma t inverse agonists using a scaffold hybridization strategy. Structure-activity relationship exploration on the amide linker, carbazole ring and arylsulfone moiety of the hybrid amide 3a led to identification of potent ROR gamma t inverse agonists. Compound 6c was found to have a good ROR gamma t activity with an IC50 of 58.5 nM in FRET assay, and reasonable inhibitory activity in mouse Th17 cell differentiation assay (58.8% inhibition at 0.3 mu M). The binding mode of carbazole carboxamides in ROR gamma t ligand binding domain was discussed. (C) 2018 Elsevier Masson SAS. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available